William Maughan
Stock Analyst at Clear Street
(4.47)
# 1,139
Out of 4,966 analysts
146
Total ratings
48.6%
Success rate
16.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Reiterated: Buy | $28 | $10.49 | +166.92% | 8 | Aug 18, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $18 | $13.81 | +30.34% | 6 | Aug 7, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $37 | $23.99 | +54.23% | 6 | Aug 5, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | $130 | $106.20 | +22.41% | 3 | Aug 5, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $31 | $17.55 | +76.64% | 7 | Jul 27, 2026 | |
| KRYS Krystal Biotech | Reiterated: Buy | $338 → $311 | $347.00 | -10.37% | 5 | May 4, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $39 → $36 | $4.59 | +684.31% | 7 | Apr 28, 2026 | |
| ANNX Annexon | Reiterated: Buy | $17 | $3.94 | +331.47% | 2 | Mar 30, 2026 | |
| CLLS Cellectis | Reiterated: Buy | $9 | $3.08 | +192.21% | 2 | Mar 20, 2026 | |
| IPSC Century Therapeutics | Reiterated: Buy | $6.6 | $1.90 | +247.37% | 10 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.15 | +92.75% | 4 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $181 → $167 | $96.73 | +72.65% | 21 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.6 | $2.70 | +70.37% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $1.27 | +923.62% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $8.53 | +427.55% | 4 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $27 | $15.78 | +71.10% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $50 | $51.72 | -3.33% | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $67 | $33.14 | n/a | 4 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $10.22 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $9 | $2.31 | n/a | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $15 | $2.91 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $24.41 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 → $106 | $143.97 | n/a | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $3.86 | n/a | 7 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $5 | $35.48 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $217.15 | n/a | 1 | Sep 5, 2022 |
Ocular Therapeutix
Aug 18, 2026
Reiterated: Buy
Price Target: $28
Current: $10.49
Upside: +166.92%
Korro Bio
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $13.81
Upside: +30.34%
Beam Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $37
Current: $23.99
Upside: +54.23%
Dianthus Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $130
Current: $106.20
Upside: +22.41%
Summit Therapeutics
Jul 27, 2026
Reiterated: Buy
Price Target: $31
Current: $17.55
Upside: +76.64%
Krystal Biotech
May 4, 2026
Reiterated: Buy
Price Target: $338 → $311
Current: $347.00
Upside: -10.37%
Wave Life Sciences
Apr 28, 2026
Reiterated: Buy
Price Target: $39 → $36
Current: $4.59
Upside: +684.31%
Annexon
Mar 30, 2026
Reiterated: Buy
Price Target: $17
Current: $3.94
Upside: +331.47%
Cellectis
Mar 20, 2026
Reiterated: Buy
Price Target: $9
Current: $3.08
Upside: +192.21%
Century Therapeutics
Mar 13, 2026
Reiterated: Buy
Price Target: $6.6
Current: $1.90
Upside: +247.37%
Mar 13, 2026
Reiterated: Buy
Price Target: $8
Current: $4.15
Upside: +92.75%
Mar 11, 2026
Reiterated: Buy
Price Target: $181 → $167
Current: $96.73
Upside: +72.65%
Mar 10, 2026
Reiterated: Buy
Price Target: $4.6
Current: $2.70
Upside: +70.37%
Mar 6, 2026
Reiterated: Buy
Price Target: $13
Current: $1.27
Upside: +923.62%
Mar 6, 2026
Reiterated: Buy
Price Target: $45
Current: $8.53
Upside: +427.55%
Feb 26, 2026
Reiterated: Buy
Price Target: $29 → $27
Current: $15.78
Upside: +71.10%
Nov 11, 2025
Reiterated: Hold
Price Target: $45 → $50
Current: $51.72
Upside: -3.33%
May 23, 2024
Reiterated: Hold
Price Target: $67
Current: $33.14
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $24
Current: $10.22
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $11 → $9
Current: $2.31
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $16 → $15
Current: $2.91
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $38
Current: $24.41
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: $91 → $106
Current: $143.97
Upside: n/a
Feb 20, 2024
Reiterated: Buy
Price Target: $60
Current: $3.86
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $10 → $5
Current: $35.48
Upside: n/a
Sep 5, 2022
Reiterated: Buy
Price Target: n/a
Current: $217.15
Upside: n/a